It seems that Spain has not been playing right cards, as that could be the reason that it has taken such steps to tackle loans, which have been keeping investors to remain at bay. Experts said that there are a number of questions that need answers, but it seems that Spain has no answers for them or has preferred to leave them unanswered.
It has been found that it is going to open SAREB, which will have 60 billion euros. Experts have been questioning the authorities concerned that do they have plans, as how they are going to manage the assets.
It seems to be quite a tense situation for Spain, as it does not have any clue as how to go about. Good news was that Spain has been able to raise 2 billion euros in the form of private capital, which was a dire need by the end of the year.
Experts said that it is not a child play to build SAREB. "There are huge logistics involved. You need lawyers, infrastructure, technological servicing. That is not set up", said experts. To develop SAREB will not be an easy thing for Spain authorities and the main expectations are from international investors.
Nvidia's newly-announced GTX 1080 graphics card is the new fastest graphics card in the world, boasting a number of noteworthy innovations.
According to Nvidia, the GTX 1080 graphics card -- which is scheduled for availability on May 27...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
China's Dakang Australia has been looking forward to sign a deal to buy Kidman, one of the Australia's biggest beef producers and owner of farm assets. However, the deal could be cancelled as the Australian government said it found that selling...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
A proposal has been put forth by a team of Google employees to the Unicode Consortium this week...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In a Monday announcement, navigation-turned-fitness-...
Swedish video game studio Starbreeze AB is working on a...
Online retail giant has listed new, customizable...
During the course of bigwig automaker BMW's annual...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).